1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 06 OCTOBER 2014

World Generic Markets 06 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - GDUFA Science Priorities Underline Direction Of Generic Market
Industry Brief - MPP Enters TAF Sublicensing Agreements
Industry Brief - Sagent Acquires Omega
Industry Brief - Abbott Completes CFR Acquisition
Industry Brief - IGI Acquires Branded And Generic Products From AstraZeneca
Industry Brief - IGI Acquires Two Products From Valeant
Industry Brief - Actavis Confirms Generic Butrans Patent Challenge
Industry Brief - Pfizer Completes InnoPharma Acquisition
Industry Brief - FDA Receives Paragraph IV Notice Letter For Kuvan Tablets
Industry Brief - Dr Reddy's Launches Levalbuterol Inhalation Solution In US
Industry Brief - Par Begins Shipment of Generic Exforge
Industry Brief - Supernus Files Topiramate Lawsuit Against Actavis
Industry Brief - Hikma Gains US Colchicine Approval
Industry Brief - Mylan Launches Lamivudine+Zidovudine In US
Industry Brief - Ranbaxy Launches New Absorica Strengths In US
Industry Brief - Intrexon/Amneal Enter Second Product Collaboration
Industry Trend Analysis - Amgen's Biosimilar Programme Progresses
Industry Brief - Perrigo Acquires Women’s Health Portfolio
Industry Brief - IntelGenx/RedHill Submit European MAA For Rizaport
Industry Brief - Arixtra Added To Navamedic’s Portfolio
Industry Brief - AMCo Launches Nicardipine, Nebivolol, In UK
Industry Brief - Epirus Enters China Collaboration With Livzon
Industry Brief - Shasun/Strides To Amalgamate
Industry Brief - Cravit/Levofloxacin sNDA Submitted In Japan
Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory

Table Of Contents

World Generic Markets 06 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.